| Literature DB >> 18543032 |
Erik Fransen1, Vedat Topsakal, Jan-Jaap Hendrickx, Lut Van Laer, Jeroen R Huyghe, Els Van Eyken, Nele Lemkens, Samuli Hannula, Elina Mäki-Torkko, Mona Jensen, Kelly Demeester, Anke Tropitzsch, Amanda Bonaconsa, Manuela Mazzoli, Angeles Espeso, Katia Verbruggen, Joke Huyghe, Patrick L M Huygen, Sylvia Kunst, Minna Manninen, Amalia Diaz-Lacava, Michael Steffens, Thomas F Wienker, Ilmari Pyykkö, Cor W R J Cremers, Hannie Kremer, Ingeborg Dhooge, Dafydd Stephens, Eva Orzan, Markus Pfister, Michael Bille, Agnete Parving, Martti Sorri, Paul Van de Heyning, Guy Van Camp.
Abstract
A multicenter study was set up to elucidate the environmental and medical risk factors contributing to age-related hearing impairment (ARHI). Nine subsamples, collected by nine audiological centers across Europe, added up to a total of 4,083 subjects between 53 and 67 years. Audiometric data (pure-tone average [PTA]) were collected and the participants filled out a questionnaire on environmental risk factors and medical history. People with a history of disease that could affect hearing were excluded. PTAs were adjusted for age and sex and tested for association with exposure to risk factors. Noise exposure was associated with a significant loss of hearing at high sound frequencies (>1 kHz). Smoking significantly increased high-frequency hearing loss, and the effect was dose-dependent. The effect of smoking remained significant when accounting for cardiovascular disease events. Taller people had better hearing on average with a more pronounced effect at low sound frequencies (<2 kHz). A high body mass index (BMI) correlated with hearing loss across the frequency range tested. Moderate alcohol consumption was inversely correlated with hearing loss. Significant associations were found in the high as well as in the low frequencies. The results suggest that a healthy lifestyle can protect against age-related hearing impairment.Entities:
Mesh:
Year: 2008 PMID: 18543032 PMCID: PMC2492985 DOI: 10.1007/s10162-008-0123-1
Source DB: PubMed Journal: J Assoc Res Otolaryngol ISSN: 1438-7573
Number of samples collected in each subsample
| City | Country | Males | Females | Total | Recruitment |
|---|---|---|---|---|---|
| Antwerp | Belgium | 556 | 606 | 1,162 | Population registries |
| Copenhagen | Denmark | 212 | 208 | 420 | Clinic |
| Cardiff | United Kingdom | 197 | 159 | 356 | Clinic |
| Gent | Belgium | 159 | 179 | 338 | Clinic+advertisement |
| Nijmegen | Netherlands | 146 | 138 | 284 | Clinic |
| Oulu | Finland | 218 | 282 | 500 | Population registries |
| Padua | Italy | 173 | 189 | 362 | Clinic+advertisement |
| Tampere | Finland | 100 | 155 | 255 | Clinic |
| Tübingen | Germany | 206 | 200 | 406 | Clinic+population registries |
| Total | 1,967 | 2,116 | 4,083 | ||
Association test between Z score and ARHI risk factors in subsamples and joint analysis
| Risk factora | Answer | Antwerp | Cardiff | Copenhagen | Ghent | Nijmegen | Oulu | Padua | Tampere | Tübingen | Joint analysisb |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Morphometry | |||||||||||
| Height | Number | ||||||||||
|
| 0.04 | 0.009 | 0.05 | ||||||||
|
| 5.4E − 5 | 0.05 | 0.02 | 0.03 | 0.007 | 0.02 |
| ||||
| BMI | Number | ||||||||||
|
| 0.03 | 0.08 | 0.08 | 7.7E − 7 |
| ||||||
|
| 6.3E − 8 | 0.06 | 0.07 | 4.0E − 5 |
| ||||||
| Medical risk factors | |||||||||||
| Heart attack | Yes/no | ||||||||||
|
| – | – | – | – | – | 0.05 | |||||
|
| 0.02 | – | – | 0.03 | – | – | – | 0.002 | |||
| CVD event | Yes/no | ||||||||||
|
| – | 0.09 | – | – | – | ||||||
|
| 0.02 | – | 0.01 | 0.048 | – | – | – |
| |||
| Noise and solvent exposure | |||||||||||
| Gunfire noise | Number | ||||||||||
| 0.01 | |||||||||||
| 0.003 | 0.009 | ||||||||||
| Occupational noise exposure | Yes/no | ||||||||||
|
| 0.01 | 0.0005 | 0.01 | 3.0E − 5 | 0.0002 | 0.01 | 0.002 | 0.001 |
| ||
|
| 0.007 | 0.01 | 0.01 | 0.02 | 0.04 |
| |||||
| Years noise exposure | Number | ||||||||||
|
| 0.09 | 0.02 | 0.007 | 0.0003 | 0.0005 | 0.002 | 0.002 | 0.005 |
| ||
|
| 0.07 | 0.06 | 0.02 | 0.06 |
| ||||||
| Solvent exposure | Yes/no | ||||||||||
|
| 0.07 | 0.07 | 0.001 | ||||||||
|
| 0.07 | ||||||||||
| Smoking | |||||||||||
| Current or former smoking | Yes/no | ||||||||||
|
| 0.01 | 0.01 | 0.03 | 0.0009 | |||||||
|
| 0.02 | 0.06 | 0.08 | ||||||||
| Smoking history (packyears) | Number | ||||||||||
|
| 0.053 | 0.001 | 0.02 | 0.006 | 0.0200 | 0.0002 |
| ||||
|
| 0.03 |
| |||||||||
| Packyears by sex (high frequency) | Number | ||||||||||
| Male | 0.02 | 0.01 | 0.08 | 0.03 | 0.0004 |
| |||||
| Fem | 0.02 | 0.02 |
| ||||||||
| Packyears by sex (low frequency) | Number | ||||||||||
| Male | 0.07 | 0.03 | 0.001 | ||||||||
| Female | 0.04 | 0.07 | |||||||||
| Smoking adjusted for CVD and BMI | Number | ||||||||||
|
| 0.03 | 0.003 | 0.01 | 0.01 | 0.06 | 0.0006 |
| ||||
|
| 0.07 | 0.008 | |||||||||
| Smoking dosage effect in smokers | Number | ||||||||||
|
| 0.09 | 0.04 | 0.001 | 0.006 |
| ||||||
|
| 0.08 | 0.08 | 0.005 | ||||||||
| Alcohol consumption | |||||||||||
| Alcohol consumption | Yes/no | ||||||||||
|
| 0.06 | 0.01 | 0.002 | 0.050 | 0.09 |
| |||||
|
| 0.01 | 0.002 | 0.006 |
| |||||||
Only significant (p < 0.05) associations or trends toward significance (p < 0.1) are shown, other cells are empty. “–” means there were not enough exposed subjects to test the risk factor.
aAn extended table with all associations tested is provided as Supplementary Table 3. The exact questions and answers as they appeared in the questionnaire are provided as Supplementary Table 4.
bValues in italics remain significant after Bonferroni correction for 74 tests (p < 6.8E − 4).
Prevalence of common diseases and smoking in ARHI and Framingham study
| Risk factor | ARHI study | Framingham study |
|---|---|---|
| Smoking | ||
| Total number of subjects | 4,102 | 1,665 |
| Percentage exposed | 47.3 | 13.5 |
| Heart attack | ||
| Total number of subjects | 4,078 | 1,662 |
| Percentage affected | 3 | 10.4 |
| Intermittent claudication | ||
| Total number of subjects | 4,074 | 1,662 |
| Percentage affected | 1 | 7.2 |
| Stroke | ||
| Total number of subjects | 4,075 | 1,664 |
| Percentage affected | 0.1 | 7 |
| Total CVD | ||
| Total number of subjects | 4,083 | 1,664 |
| Percentage affected | 2.0 | 27.8 |
| Coronary heart disease | ||
| Total number of subjects | 4,083 | 1,664 |
| Percentage affected | 1.1 | 19.4 |